AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ESCITALOPRAM OXALATE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FELIZ S 10 TABLET, COATED; ORAL | 2014/13.2.1/4924 | TORRENT EXPORTS LTD | active | 11 Dec 2030 |
| CP-ESCITALOPRAM 10 TABLET, COATED; ORAL | 2025/13.2.1/7082 | COSPHARM PHARMACEUTICALS | active | 25 Sept 2030 |
| CP-ESCITALOPRAM 20 TABLET, COATED; ORAL | 2025/13.2.1/7083 | COSPHARM PHARMACEUTICALS | active | 25 Sept 2030 |
| STALOMAC 20 TABLET, COATED; ORAL | 2024/13.2.1/6600 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
| STALOMAC 10 TABLET, COATED; ORAL | 2024/13.2.1/6599 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
ESCITALOPRAM OXALATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing ESCITALOPRAM OXALATE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ESCITALOPRAM OXALATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.